Log off SitemapDisclaimer

The 12µg/h fentanyl patch Matrifen® eases your pain

The 12µg/h fentanyl patch Matrifen® from Nycomed gives excelent pain relief for patients with severe chronic pain.

The 12µg/h fentanyl patch  - Matrifen® by NycomedThe 12µg/h fentanyl patch Matrifen® provides relief for patients with severe chronic pain such as cancer pain.

>> Information on the 12µg/h fentanyl patch Matrifen®

Matrifen® is a 12µg/h fentanyl patch, wich relieves both cancer pain, low back pain, neturopathic pain, nociceptive pain and other chronic pain.

The Matrifen® 12µg/h fentanyl patch releases fentanyl over a 3 day period and the lower drug load not only adds to a higher degree of safety, it also lowers environmental burden.

About Nycomed
Nycomed is a young company with a long history. Founded in 1874 in Norway by Morten Nyegaard, the company gradually began to expand into Europe, forming a strong position initially in the Nordic countries.

The modern story really begins in 1999, when Nycomed was established as a European company with a focus on sourcing and developing new pharmaceutical products. With this in place, the pace of this market expansion increased and the company now operates throughout Europe.

Special features

To access the site you must confirm being a healthcare professional - use the link on the left side of this page

Mode of action video

An animation presenting the Matrifen® patch;
- Application
- Mode of action

Additional material

- Product details
- Pharmacokinetics
- Technical profile
Conversion tables for download 

- Oral morphine to Matrifen (100:1)
- Oral morphine to Matrifen (150:1)
- Potency table